Abstract
Apixaban (Eliquis™) was developed by Bristol-Myers Squibb (BMS) and Pfizer to use as an antithrombotic/anticoagulant agent and has been recently approved for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. A clinical study of apixaban, sponsored by BMS and Pfizer, included a pilot exploratory portion to evaluate the potential for future drug concentration monitoring using dried blood spot (DBS) sample collection. For DBS sample collection, a fixed blood volume was dispensed onto a DBS card by either regular volumetric pipette (venous blood collection) or capillary dispenser (finger prick blood collection). A 96-well semi-automated liquid-liquid extraction sample preparation procedure was developed to provide clean extracts for UHPLC-MS/MS quantitation. Assays using both partial-spot center punch and whole spot punch were developed and validated. The linear dynamic ranges for all the analyses were from 0.5 to 500 ng/mL. The coefficient of determination (r(2)) values was >0.9944 for all the validation runs. For the center punch approach, the intra-assay precision (%CV) was within 4.4% and inter-assay precision was within 2.6%. The assay accuracy, expressed as %Dev., was within ± 5....Continue Reading
References
Jan 1, 1994·Electrophoresis·F TagliaroL Tatò
Oct 5, 2007·Journal of Medicinal Chemistry·Donald J P PintoPatrick Y S Lam
Jan 22, 2009·Analytical Chemistry·Neil SpoonerMatt Barfield
Oct 28, 2009·Analytical Chemistry·Guowen LiuMark E Arnold
Dec 18, 2009·Biomedical Chromatography : BMC·Wenkui Li, Francis L S Tse
Nov 19, 2010·Bioanalysis·Philip Denniff, Neil Spooner
Nov 19, 2010·Bioanalysis·Guowen LiuMark E Arnold
Nov 19, 2010·Bioanalysis·Celia J D'ArienzoTimothy Olah
Dec 22, 2010·Journal of Enzyme Inhibition and Medicinal Chemistry·Joseph M LuettgenAlan R Rendina
Oct 15, 2011·Analytical Chemistry·Guowen LiuMark E Arnold
Jan 19, 2012·Current Drug Targets·Ritesh AgrawalS N Dikshit
Sep 6, 2012·Bioanalysis·Roland Jw MeestersTheo M Luider
Dec 12, 2012·Bioanalysis·Long YuanMark E Arnold
Mar 19, 2013·Journal of Pharmaceutical and Biomedical Analysis·Xavier DelavenneThierry Basset
Dec 10, 2013·Journal of Pharmaceutical and Biomedical Analysis·Naiyu ZhengMark E Arnold
Apr 4, 2014·Therapeutic Drug Monitoring·Tracey GousRobert J Flanagan
Aug 22, 2014·Journal of Thrombosis and Haemostasis : JTH·E M H SchmitzD van de Kerkhof
Oct 18, 2014·Bioanalysis·Janice PursleyMark E Arnold
Citations
Sep 5, 2015·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Long YuanAnne-Françoise Aubry
Apr 27, 2016·Journal of Thrombosis and Thrombolysis·Wan-Li ZhangHuan-Jie Huang
May 24, 2016·Bioanalysis·Shirish YakkundiJames McElnay
Aug 11, 2016·Analytica Chimica Acta·Naiyu ZhengMark E Arnold
Oct 27, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Artem D RogachevNariman F Salakhutdinov
Feb 21, 2018·The Analyst·H Kočová VlčkováL Nováková
Oct 24, 2017·Bioanalysis·Anuja NigamMurali Subramanian
Oct 18, 2018·Molecular Nutrition & Food Research·Silvia YusteLaura Rubió
Jun 21, 2019·Bioanalysis·Neil SpoonerMike Lee
Mar 4, 2020·Metabolites·Kefeng LiRobert K Naviaux
Dec 8, 2020·Journal of Chromatography. a·Hui Yin Tey, Hong Heng See
Jul 10, 2018·Analytical Chemistry·Kathrin I FoersterJürgen Burhenne
Jan 11, 2020·Analytical Chemistry·Ren-Shiang JhangJiann-Shing Jeng
Aug 28, 2021·Drug Testing and Analysis·Alina A OkhinaNariman F Salakhutdinov
Jul 31, 2019·Analytical Chemistry·Divyabharathi ChepyalaChing-Hua Kuo
Sep 3, 2021·Bioanalysis·Vera de KleijneMariëtte T Ackermans